Jennifer Erdman
Psychiatric/Mental Health · Rapid City, SDNPI 1013222157
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.8% of the total across 284 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 23.1% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,547, 2.8 times the $548 reported in 2021. Among psychiatric/mental health clinicians in SD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 284 payments — averaging $20.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$795
- Alkermes, Inc.$622
- Harmony Biosciences LLC$566
- Axsome Therapeutics, Inc.$398
- Lundbeck LLC$317
- plus $2K from 14 others
What the payments were for
- Food & beverage$5,63499%
- Education$661%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 78 | $1,319 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 38 | $795 |
| Alkermes, Inc. | 30 | $622 |
| Harmony Biosciences LLC | 26 | $566 |
| Axsome Therapeutics, Inc. | 13 | $398 |
| Lundbeck LLC | 16 | $317 |
| Teva Pharmaceuticals USA, Inc. | 13 | $264 |
| Supernus Pharmaceuticals, Inc. | 15 | $254 |
| Vanda Pharmaceuticals Inc. | 6 | $231 |
| Otsuka America Pharmaceutical, Inc. | 12 | $206 |
| Neurocrine Biosciences, Inc. | 7 | $197 |
| Johnson & Johnson | 6 | $105 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $101 |
| Ironshore Pharmaceuticals Inc. | 5 | $77 |
| Corium, LLC | 2 | $59 |
| Avanir Pharmaceuticals, Inc. | 4 | $55 |
| Merck | 3 | $44 |
| Collegium Pharmaceutical, Inc. | 2 | $41 |
| Eisai Inc. | 2 | $27 |
| Jazz Pharmaceuticals Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,700 in reported general payments places this provider in the 95th percentile of 77 psychiatric/mental health providers in South Dakota.
See all psychiatric/mental health providers in South Dakota →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 14 | $22,636 |
| Vilazodone Hcl | 35 | $3,474 |
| Duloxetine Hcl | 55 | $698 |
| Bupropion XlBupropion Hcl | 21 | $503 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 13 | $450 |
| Trazodone Hcl | 44 | $419 |
| Lorazepam | 70 | $352 |
| Aripiprazole | 19 | $311 |
| Quetiapine Fumarate | 24 | $286 |
| Olanzapine OdtOlanzapine | 16 | $226 |
| Zolpidem Tartrate ErZolpidem Tartrate | 14 | $199 |
| Lamotrigine | 15 | $165 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 12 | $146 |
| Temazepam | 12 | $137 |
| Escitalopram Oxalate | 12 | $124 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $1,319 | $22,63614 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 77 psychiatric/mental health providers in South Dakota.
Other psychiatric/mental health in Rapid City
- Amy NewstromRapid City$3K
- Kristen CorkleRapid City$2K
- Lisa KautzmanRapid City$2K
- Sydnie GamrothRapid City$1K
- Steven DaryRapid City$1K
- Tamber WhiteRapid City$1K
- Kay FolandRapid City$1K
- Laura SchirberRapid City$1K
- Megan BurgardRapid City$922
- Leslie MossRapid City$918
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.